Silk-elastinlike protein polymers for matrix-mediated cancer gene therapy

Advanced Drug Delivery Reviews

Volumn 62, Issue 15, 2010, Pages 1509-1523

  Gustafson, Joshua A ^a,b   Ghandehari, Hamidreza ^a,b  

^a Department of Electrical and Computer Engineering   (United States)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

Gene delivery; Hydrogels; Recombinant polymers; Silk elastinlike protein polymers; Viral directed enzyme prodrug therapy

Indexed keywords

CANCER GENE THERAPY; CONTROLLED RELEASE SYSTEMS; GENE DELIVERY; INTRATUMORAL GENE DELIVERY; MATRIX; MONODISPERSE; PLASMID DNA; RECOMBINANT POLYMERS; SILK FIBROIN; SILK-ELASTINLIKE PROTEIN POLYMERS; SYNTHESIS AND CHARACTERIZATIONS; VIRAL DIRECTED ENZYME PRODRUG THERAPY;

AMINO ACIDS; ENZYMES; GENE THERAPY; GENE TRANSFER; HYDROGELS; MAMMALS; SILK; VIRUSES;

POLYMERS;

ELASTIN; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; GANCICLOVIR; PLASMID DNA; POLYMER; RHODAMINE 6G; RHODAMINE B; SILK ELASTINLIKE PROTEIN POLYMER; SILK FIBROIN; THEOPHYLLINE; UNCLASSIFIED DRUG;

ADENOVIRUS; AMINO ACID ANALYSIS; ATOMIC FORCE MICROSCOPY; BIOCOMPATIBILITY; BIODEGRADABILITY; BIOSYNTHESIS; CANCER CELL; CANCER GENE THERAPY; CANCER PATIENT; DRUG ACTIVITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG SAFETY; FLOW KINETICS; GELATION; GENE TARGETING; GENETIC TRANSFECTION; HEAD AND NECK CARCINOMA; HYDROGEL; IMMUNOCOMPETENCE; IN VIVO STUDY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR WEIGHT; NEUTRON SCATTERING; NONHUMAN; OUTCOME ASSESSMENT; PLASMID; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERIZATION; PRIORITY JOURNAL; REVIEW; SOLID TUMOR; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ANIMALS; BIOPOLYMERS; ELASTIN; FIBROINS; FIBRONECTINS; GENE THERAPY; HUMANS; NEOPLASMS; NUCLEAR MATRIX-ASSOCIATED PROTEINS; POLYMERS; RECOMBINANT FUSION PROTEINS;

EID: 78649876131     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2010.04.006     Document Type: Review

References (58)

1. Yu H., Wagner E. Bioresponsive polymers for nonviral gene delivery. Curr Opin Mol Ther 2009, 11:165-178.
2. Gao X., Kim K.S., Liu D. Nonviral gene delivery: what we know and what is next. AAPS J 2007, 9:E92-E104.
3. Mintzer M.A., Simanek E.E. Nonviral vectors for gene delivery. Chem. Rev. 2009, 109:259-302.
4. Green J.A., Kirwan J.M., Tierney J.F., Symonds P., Fresco L., Collingwood M., Williams C.J. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 2001, 358:781-786.
5. Berger C.C., Bokemeyer C., Schuppert F., Schmoll H.J. Endocrinological late effects after chemotherapy for testicular cancer. Br. J. Cancer 1996, 73:1108-1114.
6. Bokemeyer C., Berger C.C., Kuczyk M.A., Schmoll H.J. Evaluation of long-term toxicity after chemotherapy for testicular cancer. J Clin Oncol 1996, 14:2923-2932.
7. Carter S.K. The carcinogenic potential of cytotoxic chemotherapy and its implications for therapeutic decision-making. Cancer Chemother. Pharmacol. 1984, 12:67-69.
8. Rosner F. Is chemotherapy carcinogenic?. CA Cancer J. Clin. 1978, 28:57-59.
9. Chandler L.A., Gu D.L., Ma C., Gonzalez A.M., Doukas J., Nguyen T., Pierce G.F., Phillips M.L. Matrix-enabled gene transfer for cutaneous wound repair. Wound Repair Regen 2000, 8:473-479.
10. Peterson C.Y., Shaterian A., Borboa A.K., Gonzalez A.M., Potenza B.M., Coimbra R., Eliceiri B.P., Baird A. The noninvasive, quantitative, in vivo assessment of adenoviral-mediated gene delivery in skin wound biomaterials. Biomaterials 2009, 30:6788-6793.
11. Raut S.D., Lei P., Padmashali R.M., Andreadis S.T. Fibrin-mediated lentivirus gene transfer: Implications for lentivirus microarrays. J. Control Release 2010, 144:213-220.
12. Wang W., Li W., Ong L.L., Lutzow K., Lendlein A., Furlani D., Gabel R., Kong D., Wang J., Li R.K., Steinhoff G., Ma N. Localized and sustained SDF-1 gene release mediated by fibronectin films: a potential method for recruiting stem cells. Int. J. Artif. Organs 2009, 32:141-149.
13. Wang Y., Liu S., Li C.Y., Yuan F. A novel method for viral gene delivery in solid tumors. Cancer Res. 2005, 65:7541-7545.
14. Wang Y., Hu J.K., Krol A., Li Y.P., Li C.Y., Yuan F. Systemic dissemination of viral vectors during intratumoral injection. Mol Cancer Ther 2003, 2:1233-1242.
15. Dinerman A.A., Cappello J., Ghandehari H., Hoag S.W. Swelling behavior of a genetically engineered silk-elastinlike protein polymer hydrogel. Biomaterials 2002, 23:4203-4210.
16. Megeed Z., Cappello J., Ghandehari H. Controlled release of plasmid DNA from a genetically engineered silk-elastinlike hydrogel. Pharm. Res. 2002, 19:954-959.
17. Megeed Z., Haider M., Li D., O'Malley B.W., Cappello J., Ghandehari H. In vitro and in vivo evaluation of recombinant silk-elastinlike hydrogels for cancer gene therapy. J Control Release 2004, 94:433-445.
18. Haider M., Leung V., Ferrari F., Crissman J., Powell J., Cappello J., Ghandehari H. Molecular engineering of silk-elastinlike polymers for matrix-mediated gene delivery: biosynthesis and characterization. Mol Pharm 2005, 2:139-150.
19. Hatefi A., Cappello J., Ghandehari H. Adenoviral gene delivery to solid tumors by recombinant silk-elastinlike protein polymers. Pharm. Res. 2007, 24:773-779.
20. Cresce A.W., Dandu R., Burger A., Cappello J., Ghandehari H. Characterization and real-time imaging of gene expression of adenovirus embedded silk-elastinlike protein polymer hydrogels. Mol Pharm 2008, 5:891-897.
21. Dandu R., Ghandehari H., Cappello J. Characterization of structurally related adenovirus-laden silk-elastinlike hydrogels. J. of Bioactive and Compatible Polymers 2008, 23:5-19.
22. Dandu R., Cresce A.V., Briber R., Dowell P., Cappello J., Ghandehari H. Silk-elastinlike protein polymer hydrogels: Influence of monomer sequence on physicochemical properties. Polymer 2009, 50:366-374.
23. Hwang D., Moolchandani V., Dandu R., Haider M., Cappello J., Ghandehari H. Influence of polymer structure and biodegradation on DNA release from silk-elastinlike protein polymer hydrogels. Int J Pharm 2009, 368:215-219.
24. Greish K., Araki K., Li D., O'Malley B.W., Dandu R., Frandsen J., Cappello J., Ghandehari H. Silk-elastinlike protein polymer hydrogels for localized adenoviral gene therapy of head and neck tumors. Biomacromolecules 2009, 10:2183-2188.
25. Gustafson J., Greish K., Frandsen J., Cappello J., Ghandehari H. Silk-elastinlike recombinant polymers for gene therapy of head and neck cancer: from molecular definition to controlled gene expression. J Control Release 2009, 140:256-261.
26. Greish K., Frandsen J., Scharf S., Gustafson J., Cappello J., Ghandehari H. Silk-elastinlike recombinant polymers improve the efficacy of adenovirus thymidine kinase enzyme prodrug therapy of head and neck tumors. J. Gene Med. 2010, 12:572-579.
27. Dinerman A., Cappello J., El-Sayed M., Hoag S.W., Ghandehari H. Influence of solute charge and hydrophobicity on partitioning and diffusion in a genetically engineered silk-elastinlike protein polymer hydrogel. Macromolecular Bioscience 2010, 10:1235-1247.
28. Cappello J., Crissman J., Dorman M., Mikolajczak M., Textor G., Marquet M., Ferrari F. Genetic engineering of structural protein polymers. Biotechnol Prog 1990, 6:198-202.
29. Lucas F., Shaw J.T., Smith S.G. The amino acid sequence in a fraction of the fibroin of Bombyx mori. Biochem. J. 1957, 66:468-479.
30. Sandberg L.B., Soskel N.T., Leslie J.G. Elastin structure, biosynthesis, and relation to disease states. N Engl J Med 1981, 304:566-579.
31. Cappello J., Ferrari F. Microbial production of structural protein polymers. Plastics from Microbes 1994, 35-92. Hanser, Munich. D.P. Mobley (Ed.).
32. Cappello J. Genetically engineered protein polymers. Handbook of Biodegradable Polymers 1997, 387-416. Harwood Academic Publishers, Amsterdam. A. Domb, J. Kost, D. Wiseman (Eds.).
33. Cappello J. Synthetically designed protein polymer biomaterials. Controlled Drug Delivery: Challenges and Strategies 1997, 439-453. American Chemical Society, Washington, DC. K. Park (Ed.).
34. Ferrari F., Cappello J. Biosynthesis of protein polymers. Protein-Based Materials Bioengineering of Materials 1997, 37-60. Birkhauser, Boston. K.P. McGrath, D.L. Kaplan (Eds.).
35. Megeed Z., Cappello J., Ghandehari H. Genetically engineered silk-elastinlike protein polymers for controlled drug delivery. Adv Drug Deliv Rev 2002, 54:1075-1091.
36. Haider M., Megeed Z., Ghandehari H. Genetically engineered polymers: status and prospects for controlled release. J Control Release 2004, 95:1-26.
37. Megeed Z., Ghandehari H. Genetically engineered protein-based polymers: potential in gene delivery. Polymeric Gene Delivery: Principles and Applications 2005, 489-507. CRC Press, Boca Raton, FL. M. Amiji (Ed.).
38. Megeed Z., Ghandehari H. Recombinant polymers for drug delivery. Polymeric Drug Delivery Systems 2005, 415-452. Marcel Dekker, Inc, New York, NY. G. Kwon (Ed.).
39. Dandu R., Megeed Z., Haider M., Cappello J., Ghandehari H. Silk-elastinlike hydrogels: thermal characterization and gene delivery. Polymeric Drug Delivery Volume II - Polymeric Matrices and Drug Particle Engineering 2005, 150-168. American Chemical Society, Washington, D.C. S. Svenson (Ed.).
40. Haider M., Hatefi A., Ghandehari H. Recombinant polymers for cancer gene therapy: a minireview. J Control Release 2005, 109:108-119.
41. Dandu R., Ghandehari H. Delivery of bioactive agents from recombinant polymers. Prog. in Polymer Sci. 2007, 32:1008-1030.
42. Hatefi A., Ghandehari H. Recombinant polymers: promise for gene therapy. Control. Release So. Newsl. 2009, 26:16-18.
43. Cappello J., Crissman J.W., Crissman M., Ferrari F.A., Textor G., Wallis O., Whitledge J.R., Zhou X., Burman D., Aukerman L. In-situ self-assembling protein polymer gel systems for administration, delivery, and release of drugs. J. of Control. Release 1998, 53:105-117.
44. Dinerman A.A., Cappello J., Ghandehari H., Hoag S.W. Solute diffusion in genetically engineered silk-elastinlike protein polymer hydrogels. J. of Control. Release 2002, 82:277-287.
45. Hwang W., Kim B.H., Dandu R., Cappello J., Ghandehari H., Seog J. Surface induced nanofiber growth by self-assembly of a silk-elastin-like protein polymer. Langmuir 2009, 25:12682-12686.
46. Kad N.M., Myers S.L., Smith D.P., Smith D.A., Radford S.E., Thomson N.H. Hierarchical assembly of beta2-microglobulin amyloid in vitro revealed by atomic force microscopy. J Mol Biol 2003, 330:785-797.
47. Hortschansky P., Schroeckh V., Christopeit T., Zandomeneghi G., Fandrich M. The aggregation kinetics of Alzheimer's beta-amyloid peptide is controlled by stochastic nucleation. Protein Sci. 2005, 14:1753-1759.
48. Fezoui Y., Teplow D.B. Kinetic studies of amyloid beta-protein fibril assembly. Differential effects of alpha-helix stabilization. J Biol Chem 2002, 277:36948-36954.
49. Ilavsky J., Jemian P.R. Irena: tool suite for modeling and analysis of small-angle scattering. J. Appl. Cryst. 2009, 42:347-353.
50. Debye P., Bueche A.M. J. of Appl. Phys. 1949, 20:518-525.
51. Fritzinger B., Scheler U. Scaling behaviour of PAMAM dendrimers determined by diffusion NMR. Macromol Chem Physic 2005, 206:1288-1291.
52. Akerman B. Effects of supercoiling in electrophoretic trapping of circular DNA in polyacrylamide gels. Biophys. J. 1998, 74:3140-3151.
53. Mickel S., Arena V., Bauer W. Physical properties and gel electrophoresis behavior of R12-derived plasmid DNAs. Nucleic Acids Res. 1977, 4:1465-1482.
54. Gustafson J., Price R., Greish K., Ghandehari H. Safety of matrix-mediated adenoviral gene delivery with silk-elastinlike hydrogels. Proceedings of the 37th Annual Meeting and Exposition of the Controlled Release Society, Portland, OR July 10-14, 2010.
55. Yen M.H., Ko H.C., Tang F.I., Lu R.B., Hong J.S. Study of hepatotoxicity of naltrexone in the treatment of alcoholism. Alcohol 2006, 38:117-120.
56. Raper S.E., Chirmule N., Lee F.S., Wivel N.A., Bagg A., Gao G.P., Wilson J.M., Batshaw M.L. Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol. Genet. Metab. 2003, 80:148-158.
57. Yang Y., Li Q., Ertl H.C., Wilson J.M. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J Virol 1995, 69:2004-2015.
58. Li D., Duan L., Freimuth P., O'Malley B.W. Variability of adenovirus receptor density influences gene transfer efficiency and therapeutic response in head and neck cancer. Clin Cancer Res 1999, 5:4175-4181.